Systemic delivery of genes to striated muscles using adeno-associated viral vectors
Top Cited Papers
- 25 July 2004
- journal article
- research article
- Published by Springer Nature in Nature Medicine
- Vol. 10 (8) , 828-834
- https://doi.org/10.1038/nm1085
Abstract
A major obstacle limiting gene therapy for diseases of the heart and skeletal muscles is an inability to deliver genes systemically to muscles of an adult organism. Systemic gene transfer to striated muscles is hampered by the vascular endothelium, which represents a barrier to distribution of vectors via the circulation. Here we show the first evidence of widespread transduction of both cardiac and skeletal muscles in an adult mammal, after a single intravenous administration of recombinant adeno-associated virus pseudotype 6 vectors. The inclusion of vascular endothelium growth factor/vascular permeability factor, to achieve acute permeabilization of the peripheral microvasculature, enhanced tissue transduction at lower vector doses. This technique enabled widespread muscle-specific expression of a functional micro-dystrophin in the skeletal muscles of dystrophin-deficient mdx mice, which model Duchenne muscular dystrophy. We propose that these methods may be applicable for systemic delivery of a wide variety of genes to the striated muscles of adult mammals.Keywords
This publication has 35 references indexed in Scilit:
- Preclinical in vivo evaluation of pseudotyped adeno-associated virus vectors for liver gene therapyBlood, 2003
- Gene therapy for muscular dystrophy – a review ofpromising progressExpert Opinion on Biological Therapy, 2003
- Influence of Vector Dose on Factor IX-Specific T and B Cell Responses in Muscle-Directed Gene TherapyHuman Gene Therapy, 2002
- Micro-dystrophin cDNA ameliorates dystrophic phenotypes when introduced into mdx mice as a transgeneBiochemical and Biophysical Research Communications, 2002
- Immune Evasion by Muscle-Specific Gene Expression in Dystrophic MuscleMolecular Therapy, 2001
- Lack of Germline Transmission of Vector Sequences Following Systemic Administration of Recombinant AAV-2 Vector in MalesMolecular Therapy, 2001
- Analysis of Muscle Creatine Kinase Regulatory Elements in Recombinant Adenoviral VectorsMolecular Therapy, 2000
- Modulation of Starling Forces and Muscle Fiber Maturity Permits Adenovirus-Mediated Gene Transfer to Adult Dystrophic (mdx) Mice by the Intravascular RouteHuman Gene Therapy, 2000
- Novel Tools for Production and Purification of Recombinant Adenoassociated Virus VectorsHuman Gene Therapy, 1998
- Targeted disruption of the mouse villin gene does not impair the morphogenesis of microvilliDevelopmental Dynamics, 1998